Drug recall · April 22, 2020
Estradiol recall
Why: cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100
- Lots / codes
Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363
- Quantity
- 3,825 grams
- Company
- B & B Pharmaceuticals, Inc., Englewood, CO
- Distribution
- USA Nationwide
- Initiated
- April 14, 2020 · Voluntary: Firm initiated
- Classified
- April 16, 2020
- Reported
- April 22, 2020
- Ended
- July 24, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.